GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $830,888,000 | -0.1% | 19,087,689 | -0.1% | 0.23% | +18.9% |
Q1 2022 | $832,007,000 | -1.3% | 19,100,242 | -0.1% | 0.19% | +6.7% |
Q4 2021 | $843,114,000 | -2.6% | 19,118,226 | -15.6% | 0.18% | -10.1% |
Q3 2021 | $865,847,000 | -4.1% | 22,660,211 | -0.1% | 0.20% | -3.9% |
Q2 2021 | $902,988,000 | +27.2% | 22,676,745 | +14.0% | 0.21% | +14.4% |
Q1 2021 | $709,866,000 | +9.5% | 19,889,711 | +12.9% | 0.18% | +1.7% |
Q4 2020 | $648,410,000 | +4.4% | 17,618,548 | +6.7% | 0.18% | -7.8% |
Q3 2020 | $621,191,000 | -19.1% | 16,505,150 | -12.3% | 0.19% | -23.8% |
Q2 2020 | $768,009,000 | +37.3% | 18,828,643 | +27.5% | 0.25% | +10.0% |
Q1 2020 | $559,412,000 | +101.6% | 14,764,104 | +150.0% | 0.23% | +143.6% |
Q4 2019 | $277,507,000 | +10.2% | 5,905,666 | +0.1% | 0.09% | -2.1% |
Q3 2019 | $251,792,000 | +22.9% | 5,899,523 | +15.3% | 0.10% | +17.1% |
Q2 2019 | $204,807,000 | -0.0% | 5,117,606 | +4.4% | 0.08% | -6.8% |
Q1 2019 | $204,873,000 | +212.8% | 4,902,432 | +186.0% | 0.09% | +166.7% |
Q4 2018 | $65,496,000 | – | 1,714,100 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |